Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- ;
- University of Glasgow
- University of Oxford
- University of Nottingham
- University of Sheffield
- King's College London
- University of Cambridge
- Cardiff University
- ; Newcastle University
- ; University of East Anglia
- ; University of Leeds
- ; University of Reading
- Durham University
- KINGS COLLEGE LONDON
- Nottingham Trent University
- University of Bristol
- University of Liverpool
- University of Newcastle
- University of Northampton
- ; Cardiff University
- ; Swansea University
- ; UCL
- ; University of Nottingham
- ; University of Southampton
- ; University of Warwick
- Lancaster University
- Newcastle University
- Plymouth University
- QUEENS UNIVERSITY BELFAST
- Queen's University Belfast
- Swansea University
- The Open University
- UNIVERSITY OF DUNDEE
- UNIVERSITY OF EAST LONDON
- University of East London
- University of Hull
- 26 more »
- « less
-
Field
-
Supervisors: Prof. Reinhard J. Maurer, Prof. Scott Habershon Summary: The drug discovery pipeline involves the screening of many molecules before viable leads are identified. This involves screening
-
. The Institute of Pharmaceutical Science (IPS) is concerned with gaining a detailed understanding of the human pathological state and employing this knowledge to discover, design, develop and deliver drugs
-
will be provided to contribute towards consumables, equipment, and travel related to the project. Overview One of the major challenges in peptide therapeutics discovery for intracellular targets lies in
-
An exciting opportunity has arisen at the University of Manchester from the Wellcome Discovery Award ‘Developing Humanitarian Medicine (DHM): From Alma Ata to Bio-Tech, a History of Norms, Knowledge
-
Research UK Oxford Drug Discovery Institute (ARUK-ODDI) based at the Centre for Medicines Discovery, Nuffield Department of Medicine. You will be responsible for providing the experimental and analytical
-
management skills, with the ability to plan and prioritise own workload to meet project targets. Desirable criteria Experience with large datasets. Understanding of biomarker and drug discovery. Familiarity
-
diseases. This is a unique opportunity to grow your expertise in industry-style drug discovery within an academic setting. The bioanalytical laboratories within the DMPK group are well equipped to meet the
-
Research UK Oxford Drug Discovery Institute (ARUK-ODDI) based at the Centre for Medicines Discovery, Nuffield Department of Medicine. You will be responsible for providing the experimental and analytical
-
workload to meet project targets. Desirable criteria 1. Experience with large datasets. 2. Understanding of biomarker and drug discovery. 3. Familiarity with Fieldtrip and EEGLab software
-
, based at the Ludwig Institute in Oxford, a private Industry in Cancer Science AND Professor Fiona Ducotterd, head of drug discovery team at the Charity Alzheimer’s Research UK Drug Discovery Institute at